theMednetRegister

Rheumatology

Primary Immunodeficiency   

Questions discussed in this category

Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
1 Answer available
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
1 Answer available
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
1 Answer available
How do you decide when to obtain genetic testing for suspected autoinflammatory conditions in adults?
2 Answers available
What is your approach to working up diarrhea in an immunocompromised patient?
1 Answer available
Do you utilize post-vaccination IgG titers to detect common variable immunodeficiency in patients who are about to start or are actively on B cell depleting therapy?
2 Answers available
Does IVIG or subcutaneous Ig interfere with monoclonal antibody therapy (i.e. dupilumab, infliximab, rituximab, etc)?
How should IVIG and either biologic injections or infusions be spaced?
2 Answers available
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available
Should testing for genetic causes of HLH be performed in all patients with MAS or secondary HLH regardless of the patient's age?
2 Answers available
What is the optimal timing for Zoster vaccine administration for a patient who recently recovered from herpes zoster infection and is now planning to start B-cell depletion therapy?
1 Answer available
Is the efficacy and dose same for subcutaneous vs intravenous IVIGs being used for dermatomyositis?
1 Answer available
What are the best labs to trend improvement in HLH?
1 Answer available
What is your approach to checking IgG levels post vaccination to detect common variable immunodeficiency in patients with systemic lupus?
If a deficiency is present, do you consider IVIG to treat non-infectious symptoms such as skin rash, arthritis or hematological abnormalities? 
1 Answer available
Would you have any hesitation to use belimumab in a patient with IgA deficiency?
1 Answer available
How do you treat post-IVIG headache that is not responsive to Tylenol or NSAIDs?
Specifically, how do you treat the delayed headache, not the headache that develops during the infusion where pre-hydration and slowing down the rate ...
4 Answers available
Is there a role for antibody testing to confirm vaccine response for patients on rituximab after COVID-19 vaccination?
1 Answer available
How would you recommend dosing the MMR or other live vaccines for patients with rheumatoid arthritis on immunosuppressive medications such as anti-TNF alpha therapy?
For example, healthcare workers who require these vaccines for employment
1 Answer available
How does a history of splenectomy alter how you counsel patients on the infection risk of TNF inhibitors or other biologics?
1 Answer available
Do you recommend shingles vaccine to all immunosuppressed patients under the age of 50 y.o.?
1 Answer available
How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available


Papers discussed in this category

JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
N Engl J Med,
Clinical practice. Care of the asplenic patient.
Mediterr J Rheumatol, 2020 Jun 11
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies.
Ann Rheum Dis, 2019 Aug 14
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Lupus, 2013-02
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.
Clinical pharmacokinetics, 2018-12
Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease.
Frontiers in immunology, 2018
Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.
Clinical immunology (Orlando, Fla.), 2020 Jul 15
The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease.
The Pediatric infectious disease journal, 2018 Oct
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017 Nov 03
Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn's disease.
Pediatric blood & cancer, 2011-01
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.
Semin Arthritis Rheum, 2007 Feb
Common variable immunodeficiency in systemic lupus erythematosus.
J Clin Rheumatol, 2021 Dec 01
Intravenous Immunoglobulin for Inflammatory Myositis: Experience in a Tertiary Medical Center.
Am J Med, 1984 Mar 30
Immunoglobulin G (IgG) subclasses and human disease.
Lupus, 2007
Selective IgA deficiency in children and adults with systemic lupus erythematosus.
Autoimmun Rev, 2022 Aug 24
Efficacy and safety of intravenous immunoglobulin in patients with lupus nephritis: A systematic review of the literature.
The New England journal of medicine, 1993-12-30
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.
Lancet, 1987 May 09
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.
Int J Stroke, 2018 May 22
Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke.
Curr Rheumatol Rev, 2018
Subcutaneous IgG in the Myositis Spectrum Disorders.
Clin Rheumatol, 2014 Jan 07
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis.
The Journal of allergy and clinical immunology, 2021 Apr 20
Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
European journal of immunology, 2022 Aug 10
Secondary rituximab-associated versus primary immunodeficiencies: The enigmatic border.
The Journal of infection, 2011-11
Norovirus gastroenteritis successfully treated with nitazoxanide.
Alimentary pharmacology & therapeutics, 2006 Nov 15
Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial.
Journal of tropical medicine, 2017 Feb 26
Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country.

Related Topics in Rheumatology

Copyright © 2024 theMednet
All Rights Reserved.